• Enterprise value to EBITDA forward of NextCure, Inc. – MUN:2US0 TradingView Fri, 10 Jul 2026 04:45:20 GMT
• Piper Sandler Maintains NextCure(NXTC.US) With Buy Rating, Maintains Target Price $15 富途牛牛 Thu, 02 Jul 2026 16:41:51 GMT
• NextCure Inc. (NXTC) Q1 2026 Earnings: EPS Beat Mitigates Losses Amid Ongoing Clinical Development - Earnings Forecast Report dars.gov.et Tue, 30 Jun 2026 16:34:27 GMT
• NextCure, Inc.(NasdaqGS: NXTC) added to Russell Microcap Value Benchmark Index marketscreener.com Mon, 29 Jun 2026 13:34:00 GMT
• nextcure, inc.(nasdaqgs: nxtc) added to russell 3000e index marketscreener.com Mon, 29 Jun 2026 06:42:30 GMT
• nextcure shareholders approve expanded omnibus incentive plan TipRanks Thu, 25 Jun 2026 12:34:53 GMT
• NextCure (NASDAQ: NXTC) shareholders back amended 2019 incentive plan and director slate Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• nextcure inc. (nxtc) edges higher as biotechnology sector sees renewed interest - trade entry signals dars.gov.et Tue, 23 Jun 2026 07:00:00 GMT
• nextcure inc (nxtc) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• Director at NextCure (NASDAQ: NXTC) granted 2,340 stock options Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• NextCure (NXTC) director receives 2,340 options at $2.02 strike Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• NextCure (NASDAQ: NXTC) director receives stock options grant for 3,510 shares Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• NextCure (NXTC) director awarded options for 2,340 shares at $2.02 Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• NextCure (NXTC) director awarded 2,340 options at $2.02 exercise price Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• NextCure (NXTC) director receives grant of 2,340 stock options at $2.02 Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• nextcure stock - long-term oncology model under scrutiny AD HOC NEWS Sat, 20 Jun 2026 19:56:22 GMT
• nextcure inc (nxtc) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 08:49:58 GMT
• nextcure inc (nxtc) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 05:53:05 GMT
• nextcure inc (nxtc) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 02:23:18 GMT
• nextcure inc (nxtc) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 02:07:21 GMT
• NXTC | NextCure, Inc. Common Stock Insider Trading Quiver Quantitative Thu, 18 Jun 2026 00:57:45 GMT
• nextcure inc (nxtc) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 10:41:40 GMT
• NextCure Inc. (NXTC) Surges 12% as Biotech Sector Momentum Builds - Sell Signal Alerts dars.gov.et Wed, 17 Jun 2026 07:00:00 GMT
• NextCure Inc (NXTC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Wed, 17 Jun 2026 05:56:36 GMT
• nextcure inc (nxtc) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• nextcure inc. (nxtc) q1 2026 earnings: narrower loss beats estimates, but zero revenue weighs on shares - net income trends dars.gov.et Mon, 15 Jun 2026 07:00:00 GMT
• piper sandler maintains nextcure(nxtc.us) with buy rating, maintains target price $15 Moomoo Thu, 11 Jun 2026 07:00:00 GMT
• nxtc q1 2026 earnings: narrower loss beats estimates, no revenue yet - post-announcement reaction newsline.com Wed, 10 Jun 2026 18:30:34 GMT
• experimental drug shrinks tumors in hard-to-treat cancers Rare Cancer News Wed, 10 Jun 2026 07:00:00 GMT
• nextcure inc stock (us65343e1082): pipeline focus after restructuring and cash runway update Ad-hoc-news.de Mon, 08 Jun 2026 07:00:00 GMT
• nxtc q1 2026 earnings: narrower-than-expected loss provides modest relief amid revenue gap - one-time loss impact newsline.com Fri, 05 Jun 2026 14:35:27 GMT
• nxtc q1 2026 earnings: eps beat by 12.8% as clinical pipeline progress continues - guidance vs actual newsline.com Fri, 05 Jun 2026 00:44:34 GMT
• NextCure Inc. (NXTC) Q1 2026 Earnings: EPS Beat Driven by Lower Operating Costs, Stock Falls on Cash Runway Concerns - Guidance vs... dars.gov.et Thu, 04 Jun 2026 07:00:00 GMT
• cancer experts discuss sim0505 trial data in on-demand replay Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• nxtc announces replay available for virtual kol event discussing asco 2026 dose escalation data from phase 1 trial of sim0505 for ... The Manila Times Thu, 04 Jun 2026 07:00:00 GMT
• nextcure shares rise 2.1% after positive phase 1 cancer drug data announced at asco 2026. Pluang Wed, 03 Jun 2026 07:00:00 GMT
• lucid capital maintains nextcure(nxtc.us) with buy rating, maintains target price $25 Moomoo Tue, 02 Jun 2026 11:32:00 GMT
• NextCure, Inc. (NXTC) Discusses Preliminary Phase I Data for SIM0505 in Platinum-Resistant Ovarian Cancer and Uterine Serous Carci... Seeking Alpha Tue, 02 Jun 2026 07:00:00 GMT
• nextcure reports 55% response rate in phase 1 sim0505 trial for gynecologic cancers at asco 2026 Minichart Mon, 01 Jun 2026 14:29:00 GMT
• nextcure presents phase 1 data for sim0505 in gynecologic cancers TipRanks Mon, 01 Jun 2026 13:59:13 GMT
• NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026 Yahoo Finance Mon, 01 Jun 2026 07:00:00 GMT
• NextCure reports 55% response rate for SIM0505 in gynecologic cancers Investing.com Mon, 01 Jun 2026 07:00:00 GMT
• Strong SIM0505 Phase 1 gynecologic cancer data for NextCure (Nasdaq: NXTC) Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• NextCure presents SIM0505 Phase 1 data: 55% ORR in gynecologic cancers; cash runway into Q1 2027 TradingView Mon, 01 Jun 2026 07:00:00 GMT
• experimental ovarian and uterine cancer drug shows 55% response rate Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• nextcure reports positive sim0505 phase 1 gynecologic cancer data TipRanks Mon, 01 Jun 2026 07:00:00 GMT
• nxtc q1 2026 earnings: narrower-than-expected loss driven by cost discipline - one-time gain impact newsline.com Sun, 31 May 2026 07:00:00 GMT
• nxtc q1 2026 earnings: narrowed loss beats estimates, stock gains - product revenue analysis thelegaladvocate.com Fri, 29 May 2026 03:38:28 GMT
• nextcure inc. (nxtc) surges 5.44% as shares test key resistance - gap up stocks The Legal Advocate Fri, 29 May 2026 01:40:04 GMT
• nxtc q1 2026 earnings: narrowed loss beats estimates, stock gains - earnings yield spread newsline.com Thu, 28 May 2026 07:00:00 GMT
• nextcure (nxtc) plunges over 22% as selling pressure intensifies - wedge breakout The Legal Advocate Mon, 25 May 2026 22:38:48 GMT
• nextcure inc. (nxtc) q1 2026 earnings: eps beat amid no revenue and steep stock decline - eps growth rate The Legal Advocate Sun, 24 May 2026 07:00:00 GMT
• nextcure inc. (nxtc) gains 5.75% as biotech stock tests resistance near $10.71 - bollinger band Newser Fri, 22 May 2026 01:45:06 GMT
• nextcure inc. (nxtc) gains 5.75% as biotech stock tests resistance near $10.71 - ending diagonal newsline.com Thu, 21 May 2026 07:00:00 GMT
• nextcure stock (us65343e1082): biotech shares in focus after china licensing deal for sim0505 AD HOC NEWS Wed, 20 May 2026 07:00:00 GMT
• nextcure stock (us65343e1082): biotech shares in focus after china licensing deal for sim0505 AD HOC NEWS Tue, 19 May 2026 22:10:06 GMT
• nextcure (nxtc) q1 2026 earnings: $-1.87 eps surges past $-2.15 estimates - product revenue analysis newsline.com Tue, 19 May 2026 07:00:00 GMT
• nxtc nextcure earnings beat estimates by 67 percent yet shares retreat despite eps outperformance - community volume signals newser.com Mon, 18 May 2026 06:05:58 GMT
• nextcure stock (us65343e1082): collaboration news and cancer pipeline in focus AD HOC NEWS Sun, 17 May 2026 07:00:00 GMT
• nxtc nextcure earnings beat estimates by 67 percent yet shares retreat despite eps outperformance - subscription growth report newsline.com Sun, 17 May 2026 07:00:00 GMT
• nextcure stock (us65343e1082): biotech shares react to recent strategic update and nasdaq trading mo AD HOC NEWS Sat, 16 May 2026 17:37:53 GMT
• nextcure (nxtc) stock: down -4.98%, support test at $9.25 2026-05-15 - ad line divergence The Legal Advocate Fri, 15 May 2026 07:00:00 GMT
• lucid capital initiates nextcure(nxtc.us) with buy rating, announces target price $25 富途牛牛 Fri, 15 May 2026 00:45:29 GMT
• is nextcure (nxtc) still a buy after +11.22% rally? 2026-05-14 - mutual fund flow newsline.com Thu, 14 May 2026 07:00:00 GMT
• silverarc and devesh gandhi report 176,057 shares in nextcure (nxtc) Stock Titan Wed, 13 May 2026 07:00:00 GMT
• lucid capital markets initiates nextcure stock with buy on adc pipeline Investing.com Mon, 11 May 2026 07:00:00 GMT
• lucid capital initiates nextcure(nxtc.us) with buy rating, announces target price $25 Moomoo Mon, 11 May 2026 07:00:00 GMT
• lucid capital markets initiates coverage of nextcure (nxtc) with buy recommendation MSN Mon, 11 May 2026 07:00:00 GMT
• nxtc (nextcure) earnings beat estimates by 67 percent, yet shares retreat despite eps outperformance. - attention driven stocks Newser Mon, 11 May 2026 03:35:57 GMT
• how nextcure (nxtc) maintains its competitive edge | q4 2025: profit exceeds views - revenue per share newsline.com Fri, 08 May 2026 07:00:00 GMT
• nextcure | 8-k: nextcure provides business update and reports first quarter 2026 financial results Moomoo Thu, 07 May 2026 20:19:55 GMT
• nextcure provides business update and reports first quarter 2026 financial results Yahoo! Finance Canada Thu, 07 May 2026 07:00:00 GMT
• nextcure (nasdaq: nxtc) narrows loss but warns on going-concern and funding needs Stock Titan Thu, 07 May 2026 07:00:00 GMT
• nextcure maps june cancer data, says cash lasts into 2027 Stock Titan Thu, 07 May 2026 07:00:00 GMT
• fda fast track and narrower loss mark q1 2026 for nextcure (nasdaq: nxtc) Stock Titan Thu, 07 May 2026 07:00:00 GMT
• NextCure initiates dose optimization study for ovarian cancer drug Investing.com Mon, 04 May 2026 07:00:00 GMT
• nextcure and simcere zaiming initiate dose optimization for sim0505 (cdh6 adc) in gynecologic cancers Yahoo Finance Mon, 04 May 2026 07:00:00 GMT
• biotechnology company nextcure inc. announced it is accelerating the progress of its r&d projects by expanding its clinical resear... Bitget Mon, 04 May 2026 07:00:00 GMT
• nextcure and simcere start dose optimization for sim0505 in platinum-resistant ovarian cancer. Pluang Mon, 04 May 2026 07:00:00 GMT
• nextcure moves ovarian cancer drug into dose testing before asco Stock Titan Mon, 04 May 2026 07:00:00 GMT
• biotechnology company nextcure inc. announced it is accelerating the progress of its r&d projects by expanding its clinical resear... Bitget Sun, 03 May 2026 20:15:58 GMT
• what capacity utilization nextcure (nxtc)? (-2.47%) 2026-04-27 - combination correction The Legal Advocate Mon, 27 Apr 2026 07:00:00 GMT
• nextcure inc expected to post a loss of $1.81 a share - earnings preview TradingView Mon, 27 Apr 2026 07:00:00 GMT
• nextcure (nxtc) stock rejected order (smart money exits) 2026-04-24 - top analyst picks Newser Sat, 25 Apr 2026 03:36:19 GMT
• nextcure (nasdaq: nxtc) plans 2026 meeting, auditor, pay and equity plan votes Stock Titan Fri, 24 Apr 2026 07:00:00 GMT
• nextcure (nxtc) stock rejected order (smart money exits) 2026-04-24 - percent above ma The Legal Advocate Fri, 24 Apr 2026 07:00:00 GMT
• nextcure to present sim0505 cancer drug data at asco meeting by investing.com Investing.com Nigeria Wed, 22 Apr 2026 08:34:53 GMT
• NextCure and Simcere Announce Presentation of Phase 1 Data for SIM0505 at ASCO 2026 | NXTC Stock News Quiver Quantitative Tue, 21 Apr 2026 07:00:00 GMT
• nextcure to present sim0505 cancer drug data at asco meeting Investing.com Tue, 21 Apr 2026 07:00:00 GMT
• nextcure and simcere’s sim0505 (cdh6 adc) phase 1 data to be presented at asco 2026 The Manila Times Tue, 21 Apr 2026 07:00:00 GMT
• nextcure inc stock (us65343e1082): is its immunotherapy pipeline strong enough to unlock biotech ups AD HOC NEWS Mon, 20 Apr 2026 02:25:57 GMT
• nxtc forecast, price target & analyst ratings | nextcure inc (nasdaq:nxtc) ChartMill Fri, 17 Apr 2026 07:00:00 GMT
• is nextcure incs roic above industry average - 2026 summary & growth focused entry point reports baoquankhu1.vn Thu, 09 Apr 2026 17:15:25 GMT
• surprises report: is nextcure inc stock good for income investors - new guidance & safe entry trade signal reports baoquankhu1.vn Wed, 08 Apr 2026 20:26:11 GMT
• activity recap: is nextcure inc a defensive stock - 2026 news drivers & stepwise entry and exit trade signals baoquankhu1.vn Wed, 08 Apr 2026 14:05:11 GMT
• is nextcure (nxtc) stock heavily shorted | price at $12.10, up 8.67% - pcr mean reversion The Legal Advocate Wed, 08 Apr 2026 07:00:00 GMT
• value recap: how is nextcure inc managing supply chain issues - 2026 geopolitical influence & verified short-term plans baoquankhu1.vn Tue, 07 Apr 2026 23:00:47 GMT
• nextcure receives fast track designation for sim0505 (cdh6 adc) in ovarian cancer Bitget Tue, 07 Apr 2026 07:00:00 GMT
• fda fast-tracks nextcure ovarian cancer drug ahead of asco data Stock Titan Tue, 07 Apr 2026 07:00:00 GMT
• nextcure gets fda fast track for sim0505 in ovarian cancer National Today Tue, 07 Apr 2026 07:00:00 GMT
• nextcure receives fast track designation for sim0505 (cdh6 adc) in ovarian cancer Bitget Mon, 06 Apr 2026 21:06:43 GMT
• nxtc earning date, earning analysis and earning prediction Intellectia AI Fri, 03 Apr 2026 13:50:12 GMT
• nxtc stock analysis: nextcure inc. biotech gains 1.80 percent to 10.72 support level newsline.com Fri, 03 Apr 2026 07:00:00 GMT
• nextcure and simcere’s sim0505 (cdh6 adc) abstract accepted for asco 2026 The Manila Times Wed, 01 Apr 2026 07:00:00 GMT
• nextcure and simcere’s sim0505 (cdh6 adc) abstract accepted for asco 2026 The Manila Times Tue, 31 Mar 2026 20:18:15 GMT
• phase 1 cancer drug abstract lands asco 2026 slot in chicago Stock Titan Tue, 31 Mar 2026 07:00:00 GMT
• bond watch: is nextcure inc stock showing strong momentum - quarterly portfolio summary & verified entry point signals baoquankhu1.vn Sat, 28 Mar 2026 11:13:42 GMT
• buy signal: is nextcure inc a defensive stock - quarterly trade review & growth-oriented investment plans baoquankhu1.vn Thu, 26 Mar 2026 00:31:26 GMT
• buy signal: is nextcure inc a defensive stock - quarterly trade review & growth-oriented investment plans baoquankhu1.vn Wed, 25 Mar 2026 12:31:13 GMT
• 12 health care stocks moving in monday's after-market session Benzinga Mon, 23 Mar 2026 07:00:00 GMT
• market recap: is nextcure inc a defensive stock - weekly profit analysis & expert approved momentum ideas baoquankhu1.vn Sun, 22 Mar 2026 23:08:11 GMT
• travel stocks: is nextcure inc stock good for income investors - trade risk assessment & ai forecast swing trade picks baoquankhu1.vn Tue, 17 Mar 2026 00:40:59 GMT
• nextcure inc stock (isin: us65343e1082) faces analyst downgrade amid biotech sector headwinds AD HOC NEWS Sat, 14 Mar 2026 07:00:00 GMT
• nextcure stock soars after-hours on promising preclinical data for rare bone disease treatment MSN Sun, 08 Mar 2026 13:48:37 GMT
• is nextcure inc. stock ready for breakout - weekly market summary & weekly return optimization alerts Naître et grandir Sat, 07 Mar 2026 13:56:45 GMT
NextCure, Inc(NASDAQ:NXTC) 
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment o...
Website: http://www.nextcure.com
IPO Price: $15 (May 08, 2019)
Full Time Employees: 69
CEO: Michael S. Richman
Sector: Healthcare
Industry: Biotechnology